NexImmune Analyst Ratings
NexImmune Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 08/16/2022 | 325.53% | Barclays | $7 → $2 | Maintains | Overweight |
| 08/16/2022 | 538.3% | Raymond James | $12 → $3 | Maintains | Outperform |
| 06/01/2022 | 963.83% | BTIG | → $5 | Initiates Coverage On | → Buy |
| 04/01/2022 | 1389.36% | Barclays | $4 → $7 | Maintains | Overweight |
| 02/22/2022 | 2665.96% | Raymond James | $21 → $13 | Maintains | Outperform |
| 11/15/2021 | 4368.09% | Raymond James | $30 → $21 | Maintains | Outperform |
| 04/01/2021 | 6282.98% | Raymond James | → $30 | Initiates Coverage On | → Outperform |
| 03/09/2021 | 7346.81% | Cantor Fitzgerald | → $35 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 11/15/2022 | — | 雷蒙德·詹姆 | 降级 | 跑赢大盘 → 市场表现 | |
| 08/16/2022 | 325.53% | 巴克莱 | 7 美元 → 2 美元 | 维护 | 超重 |
| 08/16/2022 | 538.3% | 雷蒙德·詹姆 | 12 美元 → 3 美元 | 维护 | 跑赢大盘 |
| 06/01/2022 | 963.83% | BTIG | → 5 美元 | 开启覆盖范围 | → 购买 |
| 04/01/2022 | 1389.36% | 巴克莱 | 4 美元 → 7 美元 | 维护 | 超重 |
| 2022 年 2 月 22 日 | 2665.96% | 雷蒙德·詹姆 | 21 美元 → 13 美元 | 维护 | 跑赢大盘 |
| 11/15/2021 | 4368.09% | 雷蒙德·詹姆 | 30 美元 → 21 美元 | 维护 | 跑赢大盘 |
| 04/01/2021 | 6282.98% | 雷蒙德·詹姆 | → 30 美元 | 开启覆盖范围 | → 跑赢大盘 |
| 03/09/2021 | 7346.81% | 坎托·菲茨杰拉德 | → 35 美元 | 开启覆盖范围 | → 超重 |
What is the target price for NexImmune (NEXI)?
nexiMune（NEXI）的目标价格是多少？
The latest price target for NexImmune (NASDAQ: NEXI) was reported by Raymond James on November 15, 2022. The analyst firm set a price target for $0.00 expecting NEXI to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
雷蒙德·詹姆斯于2022年11月15日公布了Neximmune（纳斯达克股票代码：NEXI）的最新目标股价。这家分析公司将目标价设定为0.00美元，预计NEXI将在12个月内降至-100.00％（可能下跌-100.00％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for NexImmune (NEXI)?
NeximMune（NEXI）的最新分析师评级是多少？
The latest analyst rating for NexImmune (NASDAQ: NEXI) was provided by Raymond James, and NexImmune downgraded their market perform rating.
Neximmune（纳斯达克股票代码：NEXI）的最新分析师评级由雷蒙德·詹姆斯提供，NeximMune下调了他们的市场表现评级。
When is the next analyst rating going to be posted or updated for NexImmune (NEXI)?
NeximMune（NEXI）的下一个分析师评级将在何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NexImmune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NexImmune was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与Neximmune的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。NeximMune的最新评级是在2022年11月15日提交的，因此您应该预计下一个评级将在2023年11月15日左右公布。
Is the Analyst Rating NexImmune (NEXI) correct?
分析师评级 nexiMune (NEXI) 正确吗？
While ratings are subjective and will change, the latest NexImmune (NEXI) rating was a downgraded with a price target of $0.00 to $0.00. The current price NexImmune (NEXI) is trading at is $0.47, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Neximmune（NEXI）评级被下调，目标价为0.00美元至0.00美元。Neximmune（NEXI）目前的交易价格为0.47美元，超出了分析师的预测区间。